| 产品标题 |
产品货号 |
产品规格 |
厂家 |
| Human Lymphoid tissue; Lymphoma, extranodal marginal zone B-cell from ORIGENE TECHNOLOGIES | CS512471 | 5x5um | ORIGENE TECHNOLOGIES |
| Human sulfatase modifying factor 1 (SUMF1) from ORIGENE TECHNOLOGIES | TP720417 | 10 ug | ORIGENE TECHNOLOGIES |
| Human sulfatase modifying factor 1 (SUMF1) from ORIGENE TECHNOLOGIES | TP311092 | 20 ug | ORIGENE TECHNOLOGIES |
| Human sulfatase modifying factor 2 (SUMF2), transcript variant 2 from ORIGENE TECHNOLOGIES | TP313137 | 20 ug | ORIGENE TECHNOLOGIES |
| Cancer/testis antigen 1B (CTAG1B/NY-ESO-1) from ORIGENE TECHNOLOGIES | LY400527 | 100 ug | ORIGENE TECHNOLOGIES |
| Cancer/testis antigen 62 (CT62) from ORIGENE TECHNOLOGIES | LY420183 | 100 ug | ORIGENE TECHNOLOGIES |
| Cancer/testis antigen family 45, member A1 (CT45A1) from ORIGENE TECHNOLOGIES | LY422786 | 100 ug | ORIGENE TECHNOLOGIES |
| Cancer/testis antigen 2 (CTAG2), transcript variant 1 from ORIGENE TECHNOLOGIES | LY406703 | 100 ug | ORIGENE TECHNOLOGIES |
| Cancer/testis antigen family 45, member A2 (CT45A2) from ORIGENE TECHNOLOGIES | LY403478 | 100 ug | ORIGENE TECHNOLOGIES |
| Cancer/testis antigen family 45, member A3 (CT45A3) from ORIGENE TECHNOLOGIES | LY422732 | 100 ug | ORIGENE TECHNOLOGIES |
| Cancer/testis antigen family 45, member A4 (CT45A4) from ORIGENE TECHNOLOGIES | LY422733 | 100 ug | ORIGENE TECHNOLOGIES |
| Cancer/testis antigen family 45, member A6 (CT45A6) from ORIGENE TECHNOLOGIES | LY422735 | 100 ug | ORIGENE TECHNOLOGIES |
| Cancer/testis antigen family 47, member A1 (CT47A1) from ORIGENE TECHNOLOGIES | LY421602 | 100 ug | ORIGENE TECHNOLOGIES |
| Cancer/testis antigen family 47, member A10 (CT47A10) from ORIGENE TECHNOLOGIES | LY421593 | 100 ug | ORIGENE TECHNOLOGIES |
| Cancer/testis antigen family 47, member A2 (CT47A2) from ORIGENE TECHNOLOGIES | LY421601 | 100 ug | ORIGENE TECHNOLOGIES |
| Cancer/testis antigen family 47, member A3 (CT47A3) from ORIGENE TECHNOLOGIES | LY421600 | 100 ug | ORIGENE TECHNOLOGIES |
| Cancer/testis antigen family 47, member A5 (CT47A5) from ORIGENE TECHNOLOGIES | LY421598 | 100 ug | ORIGENE TECHNOLOGIES |
| Cancer/testis antigen family 47, member A6 (CT47A6) from ORIGENE TECHNOLOGIES | LY421597 | 100 ug | ORIGENE TECHNOLOGIES |
| Cancer/testis antigen family 47, member A7 (CT47A7) from ORIGENE TECHNOLOGIES | LY421596 | 100 ug | ORIGENE TECHNOLOGIES |
| Cancer/testis antigen family 47, member A9 (CT47A9) from ORIGENE TECHNOLOGIES | LY421594 | 100 ug | ORIGENE TECHNOLOGIES |
| Cancer/testis antigen family 47, member A8 (CT47A8) from ORIGENE TECHNOLOGIES | LY421595 | 100 ug | ORIGENE TECHNOLOGIES |
| Cancer/testis antigen family 45, member A5 (CT45A5), transcript variant 1 from ORIGENE TECHNOLOGIES | LY423509 | 100 ug | ORIGENE TECHNOLOGIES |
| Human GLI pathogenesis-related 2 (GLIPR2) from ORIGENE TECHNOLOGIES | TP317501 | 20 ug | ORIGENE TECHNOLOGIES |
| KMT2C - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN417005 | 1 kit | ORIGENE TECHNOLOGIES |
| Kmt5c - mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN317008 | 1 kit | ORIGENE TECHNOLOGIES |
| KMT2D - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN421064 | 1 kit | ORIGENE TECHNOLOGIES |
| KMT2E - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN414671 | 1 kit | ORIGENE TECHNOLOGIES |
| Kmt2e - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN508951 | 1 kit | ORIGENE TECHNOLOGIES |
| JMY - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN413595 | 1 kit | ORIGENE TECHNOLOGIES |
| Jmy - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN508557 | 1 kit | ORIGENE TECHNOLOGIES |
| JMY Mass Spectrometry Standard from ORIGENE TECHNOLOGIES | PH313595 | 10 ug | ORIGENE TECHNOLOGIES |
| GAMT - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN400528 | 1 kit | ORIGENE TECHNOLOGIES |
| Gamt - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN506297 | 1 kit | ORIGENE TECHNOLOGIES |
| GAMT Mass Spectrometry Standard from ORIGENE TECHNOLOGIES | PH316741 | 10 ug | ORIGENE TECHNOLOGIES |
| GAMT Mass Spectrometry Standard from ORIGENE TECHNOLOGIES | PH300528 | 10 ug | ORIGENE TECHNOLOGIES |
| Aldo-keto reductase family 7-like (AKR7L), transcript variant 1 from ORIGENE TECHNOLOGIES | LY404587 | 100 ug | ORIGENE TECHNOLOGIES |
| Aldo-keto reductase family 7, member A2 (aflatoxin aldehyde reductase) (AKR7A2) from ORIGENE TECHNOLOGIES | LY418497 | 100 ug | ORIGENE TECHNOLOGIES |
| Aldo-keto reductase family 7, member A3 (aflatoxin aldehyde reductase) (AKR7A3) from ORIGENE TECHNOLOGIES | LY416002 | 100 ug | ORIGENE TECHNOLOGIES |
| GPT - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN403756 | 1 kit | ORIGENE TECHNOLOGIES |
| GPT2 - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN409119 | 1 kit | ORIGENE TECHNOLOGIES |
| Gpt - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN507284 | 1 kit | ORIGENE TECHNOLOGIES |
| Gpt2 - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN507285 | 1 kit | ORIGENE TECHNOLOGIES |
| GPT Mass Spectrometry Standard from ORIGENE TECHNOLOGIES | PH303756 | 10 ug | ORIGENE TECHNOLOGIES |
| GPT2 Mass Spectrometry Standard from ORIGENE TECHNOLOGIES | PH309119 | 10 ug | ORIGENE TECHNOLOGIES |
| EEPD1 - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN408988 | 1 kit | ORIGENE TECHNOLOGIES |
| Eepd1 - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN505019 | 1 kit | ORIGENE TECHNOLOGIES |
| Human MPN domain containing (MPND) from ORIGENE TECHNOLOGIES | TP307440 | 20 ug | ORIGENE TECHNOLOGIES |
| Human PNMA-like 2 (PNMAL2) from ORIGENE TECHNOLOGIES | TP313508 | 20 ug | ORIGENE TECHNOLOGIES |
| EXOSC1 - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN406007 | 1 kit | ORIGENE TECHNOLOGIES |
| EXOSC6 - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN408634 | 1 kit | ORIGENE TECHNOLOGIES |